Apsen Farmaceutica S.a.
Clinical trials sponsored by Apsen Farmaceutica S.a., explained in plain language.
-
Can an old malaria drug help fight severe COVID-19?
Disease control CancelledThis Phase 3 trial tests whether hydroxychloroquine, given alone or with azithromycin, can improve outcomes for adults hospitalized with moderate to severe COVID-19 lung disease. Participants receive hydroxychloroquine for 10 days, and some also get azithromycin for 5 days. Resea…
Phase 3 • Sponsor: Apsen Farmaceutica S.A. • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Two drugs go Head-to-Head for easing enlarged prostate symptoms
Symptom relief CancelledResearchers are comparing two drugs, naftopidil and tamsulosin, to see which better eases urinary symptoms in men with benign prostatic hyperplasia, a non-cancerous enlargement of the prostate. The study enrolls men aged 50 and older who have moderate to severe urinary symptoms, …
Phase 3 • Sponsor: Apsen Farmaceutica S.A. • Aim: Symptom relief
Last updated Sep 11, 2026 00:00 UTC
-
Can a daily pill quiet the spinning of vertigo?
Symptom relief CancelledResearchers are testing an experimental oral tablet called APSLXR in people with Meniere's disease or vertigo of vestibular origin. The main goal is to check whether the drug is safe when taken once a day for 60 days. A small group will also have blood tests to see how the body p…
Phase 1 • Sponsor: Apsen Farmaceutica S.A. • Aim: Symptom relief
Last updated Sep 10, 2026 00:00 UTC